MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-33-0202027
Vitane Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹96.05 Cr
▼ 3% YoY
Net profit · FY 2025
₹2.5 Cr
Net margin 2.6%
EBITDA · FY 2025
₹5.35 Cr
EBITDA margin 5.6%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹15.27 Cr
Issued & subscribed
Open charges
₹27.96 Cr
Satisfied ₹35 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
22
Provident fund records
About Vitane Pharmaceuticals Private Limited
Data last updated:
Vitane Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC163987. Its GSTIN is 27AACCV3000C1Z1 (Maharashtra). The company holds 5 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹15.27 Cr. It is led by directors Mohammed Hussain Sadiq and Mirza Sajjad Baig.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.05 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.5 Cr (net margin 2.6%) and EBITDA of ₹5.35 Cr (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 52% over five years.
The company has about 22 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹27.96 Cr and satisfied charges of ₹35 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending. The company has 7 deals on record (3 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹16.92 Cr; the latest was in December 2018. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Vea Impex (I) Private Limited with revenue of ₹96.93 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 16 overdue payments to 16 micro and small suppliers.
Vitane Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0202027). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vitanepharma.com.
Company Details of Vitane Pharmaceuticals Private Limited
CIN U24239MH2006PTC163987
Registration Number 163987
Incorporation Date 23 August 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0202027
Recognitions & Rankings of Vitane Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressBhoomi Velocity 601 6th Floor Plot No.B – 39 B – 39A & B – 39A1 Road No. 23 MIDC. Wag, Le Estate, Thane, Maharashtra, India – 400604
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Vitane Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Vitane Pharmaceuticals Private Limited
The main business activity of Vitane Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vitane Pharmaceuticals Private Limited FY 2025 filings available
Vitane Pharmaceuticals Private Limited reported revenue of ₹96.05 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹96.05 Cr ▼ 3%
Net profit · FY 2025
₹2.5 Cr margin 2.6%
EBITDA · FY 2025
₹5.35 Cr margin 5.6%
Compounded Annual Growth Rate (CAGR) of Vitane Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 8%
5 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 38%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vitane Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.35 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.5 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vitane Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vitane Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Hussain Sadiq | Director | 23 Aug 2006 | 20 Years 1 Months | Current |
| Mirza Sajjad Baig Also directs: Intracell Therapeutics Private Limited, Vitane Biologics Private Limited, M.S.B Agritech Private Limited and 2 more | Director | 30 May 2012 | 14 Years 4 Months | Current |
Peer Comparison of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vea Impex (I) Private Limited | ₹96.93 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Hospimax Healthcare Private Limited | ₹96.45 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Medico Intercontinental Limited Listed | ₹96.37 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Ahmedabad, Gujarat, India |
| Priche Generics Private Limited | ₹96.36 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Hyderabad, Telangana, India |
| Novo Medi Sciences Private Limited | ₹96.23 Cr (FY 2023) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Vitane Pharmaceuticals Private Limited this company | ₹96.05 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Thane, Maharashtra, India |
| Fulford (India) Private Limited | ₹95.86 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Mumbai, Maharashtra, India |
| Guntur Institute of Oncology Private Limited | ₹95.46 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Guntur, Andhra Pradesh, India |
| Rohan Pharma Private Limited | ₹95.01 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| Paras Medical Agency Private Limited | ₹94.68 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Dombivli East, Maharashtra, India |
| Aurore Pharmaceuticals Private Limited | ₹94.5 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Vitane Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Vitane Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vitane Pharmaceuticals Private Limited
Open charges
₹27.96 Cr
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2024 | State Bank of India | ₹22 Cr | Open |
| 20 Feb 2018 | Others | ₹2.64 Cr | Open |
| 16 Mar 2016 | Others | ₹3.32 Cr | Open |
| 20 Dec 2016 | Others | ₹35 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited has 7 deals on record (3 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹16.92 Cr; the latest was in December 2018.
Total deals
7
Rights issues
3
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹16.92 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2018 | Funding round | ₹15.05 Cr | Investors: Peace World General Trading LLC |
| Apr 2018 | Rights issue | ₹45.7 Lakh | Investors: an individual |
| Feb 2017 | Rights issue | ₹10.29 Cr | Investors: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Nov 2014 | Rights issue | ₹9.9 Cr | Investors: an individual |
Premium access
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited has 4 court cases on record: 1 filed by Vitane Pharmaceuticals, 2 filed against it, 1 where it is another party. 2 cases are pending and 2 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Total cases
4
Filed by the company
1
Filed against the company
2
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (COS) | Company is another party | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana and 4Others | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
| District court, KOPPAL, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Drugs Inspector Koppal Circle, Koppal | Disposed |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 16 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Omkar Traders R & D | •••• | •••• | •••• |
| Peersan Aircon Systems. | •••• | •••• | •••• |
| Vision India Sales and Services | •••• | •••• | •••• |
| Shubh Flavour and Fragrances Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited has a workforce of 22 employees as of Mar 28, 2024.
Employee count
22
Active EPFO establishments
1
Employee growth
-12%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Intracell Therapeutics Private Limited | U24100MH2013PTC240329 | Locked |
| Vitane Biologics Private Limited | U74999TG2006PTC051463 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity on Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Vijay Mukesh Thakkar ceased to be Company Secretary on 04 Nov 2022.
AGM
Vitane Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vitane Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with State Bank Of India amounted to Rs. 22.00 Cr with Charge ID 100999587 was registered on 16 Oct 2024.
Ceased
Vijay Mukesh Thakkar ceased to be Company Secretary.
Charges
A charge registered on 20 Dec 2016 via Charge ID 100115466 with Others was fully satisfied on 12 Apr 2021.
Charges
A charge with Others of Rs. 2.64 Cr registered on 20 Feb 2018 with Charge ID 100160693 was modified on 24 Jul 2020.
Charges
A charge with Others amounted to Rs. 2.64 Cr with Charge ID 100160693 was registered on 20 Feb 2018.
Charges
A charge with Others amounted to Rs. 35.00 Cr with Charge ID 100115466 was registered on 20 Dec 2016.
Charges
A charge with Others amounted to Rs. 3.32 Cr with Charge ID 100018473 was registered on 16 Mar 2016.
Ceased
Mohameed Mohameed Iqbal Mohammed Hassan ceased to be Director.
Appointed
Mirza Sajjad Baig was appointed as Director.
Appointed
Mohammed Hussain Sadiq was appointed as Director.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vitane Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vitane Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals has 5 GST registrations: 1 active and 4 cancelled or inactive.
Total GSTINs
5
Active
1
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV3000C1Z1 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vitane Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitane Pharmaceuticals Private Limited
Vitane Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 August 2006 (20+ years old) and is registered under CIN U24239MH2006PTC163987.
Vitane Pharmaceuticals reported revenue of ₹96.05 Cr for FY 2025 (down 3% YoY).
Vitane Pharmaceuticals has 2 current directors:
- Mohammed Hussain Sadiq - Director
- Mirza Sajjad Baig - Director
Vitane Pharmaceuticals reported a net profit of ₹2.5 Cr (net margin 2.6%) and EBITDA of ₹5.35 Cr (EBITDA margin 5.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vitane Pharmaceuticals is 8% over three years and 52% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vitane Pharmaceuticals is 27AACCV3000C1Z1, registered in Maharashtra. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.
The CIN (Corporate Identification Number) of Vitane Pharmaceuticals is U24239MH2006PTC163987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitane Pharmaceuticals has 4 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Vitane Pharmaceuticals was incorporated on 23 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Vitane Pharmaceuticals has 7 deals on record (3 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹16.92 Cr; the latest was in December 2018.
The peers of Vitane Pharmaceuticals by revenue are Vea Impex (I) Private Limited, Hospimax Healthcare Private Limited, Medico Intercontinental Limited, Priche Generics Private Limited, Novo Medi Sciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Vijay Mukesh Thakkar ceased to be Company Secretary on 04 Nov 2022. Mohameed Mohameed Iqbal Mohammed Hassan ceased to be Director on 13 Jun 2012. Mirza Sajjad Baig was appointed as Director on 30 May 2012. Vitane Pharmaceuticals has 4 board changes on record in total.